Dear Fellow Skeptic,
On January 4th, 2019, super-investor Dylan Jovine recommended shares of Loxo Oncology... 3 days later it was taken over for a super-fast 71% gain...
On October 19th of 2018 he recommended Pacific Biosciences... 4 days later it was taken over for a quick 72% gain...
And on October 1st of 2018, he recommended shares of Tesaro... 63 days later it was taken over for an easy 91% profit.
Dylan has just recommended his next takeover. You can find out about it here >>>
The tiny biotech he recommended just won a patent on a new kind of genetic software that can "Cut & Paste" any disease from your body.
| • | | The Nobel Prize Committee is calling it "The Holy Grail of Medicine" | | | | • | | The Wall Street Journal reports the company is "transforming medicine." | | | | • | | 60 Minutes reports the company is "revolutionizing the search for new drugs." | | | And Dylan says it reminds him of Array Biopharma, which was taken over by Pfizer on July 30, 2019, handing investors who followed his recommendation fast 148% profits.
Learn the name of this company right now >>>
Sincerely,
Brad Sullivan
Publisher
Behind the Markets
| | From time to time your free Options Profits Daily newsletter subscription is supplemented by paid sponsorships, like the one above. Please read all disclaimers. Rest assured that your information was not shared with this sponsor. Please note that Options Profits Daily has not independently reviewed the validity of the claims or statements contained within this sponsorship, and we are not responsible for any errors or omissions.
Never invest in a security or idea featured on our site or in our emails unless you can afford to lose your entire investment. We are not registered investment advisors or brokers/dealers and we do not purport to be. We make no representations, warranties or guarantees as to the accuracy or completeness of the content featured on our site or in our emails. Furthermore, the article authors and contributors featured on this site may own securities mentioned in their articles and not disclose this information. Options Profits Daily does not endorse any investing or trading products or newsletters advertised in this email or on our web site. Please be sure to read our
Go here to get more information from |  | | | | | |
No comments:
Post a Comment